Lupus Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Group 1 (Exposed group – for people who have taken anifrolumab):

• You are currently pregnant or were pregnant within the last year
• You have been diagnosed with moderate or severe lupus (SLE)
• You are willing to give your consent to take part in the study
• You agree to allow your doctor(s) to share your health information with the registry
• You have received at least one dose of the medication anifrolumab at any point during your pregnancy

Group 2 (Unexposed group – for people who have NOT taken anifrolumab):

• You are currently pregnant or were recently pregnant
• You have been diagnosed with moderate or severe lupus (SLE)
• You are willing to give your consent to take part in the study
• You agree to allow your doctor(s) to share your health information with the registry
• You are taking or have taken other medications to treat your moderate or severe lupus during pregnancy

Who may not be able to join:

Group 1 (Exposed group):

• Your pregnancy has already ended before you first made contact with the study team to enroll
• You were exposed during pregnancy to medications known to cause birth defects, or to experimental/investigational medications

Group 2 (Unexposed group):

• Your pregnancy has already ended before you first made contact with the study team to enroll
• You were exposed during pregnancy to medications known to cause birth defects, or to experimental/investigational medications

Important: Always verify eligibility with the trial site directly before applying.